You don’t have to be a shareholder or a corporate sympathizer to wonder if there’s something fishy about China’s vigorous campaign against foreign pharmaceutical companies. In the last two months, four major Western firms have been accused of corruption by Chinese regulators or media, in the midst of a probe by Beijing into health care price fixing.
Read Full Article »
